Inion focuses on the development and commercialization of biodegradable plates, screws, pins, and membranes used to enhance the healing of bone and soft tissue injuries. Their expertise lies in designing and manufacturing implants from their proprietary biomaterials, allowing them to create implants tailored for specific surgical applications in terms of strength, flexibility, and degradation rate. Founded in 1999, Inion is headquartered in Tampere, Finland, and targets strategic markets in the USA and select territories worldwide through a network of specialist distributors.